Aging Population And AI Integration Will Expand Oncology Market

Published
16 May 25
Updated
20 Aug 25
AnalystConsensusTarget's Fair Value
SEK 365.00
26.0% undervalued intrinsic discount
20 Aug
SEK 270.00
Loading
1Y
72.0%
7D
-1.5%

Author's Valuation

SEK 365.0

26.0% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on20 Aug 25
Fair value Increased 6.31%

RaySearch Laboratories’ consensus analyst price target was raised to SEK365.00, primarily reflecting a higher anticipated future P/E multiple, indicating improved growth or earnings expectations. What's in the News RaySearch will showcase major innovations at AAPM 2025, including advanced adaptive replanning, AI-driven image segmentation, and upgraded Plan Explorer in RayStation; RayCare and RayIntelligence integrations and workflows will be spotlighted.